Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Perspective · 2021Exact title match Research article · 2009 Regrowth Concentration Zero (RC0) as Complementary Endpoint Parameter to Evaluate Compound Candidates During Preclinical Drug Development for Cancer Treatment
The screening process for potential anticancer drugs involves expensive and time consuming
Opinion · 12 Apr 2024 Advancements in In Vitro and In Vivo Models for Preclinical Drug Development
Commentary · 23 Dec 2021 Pre and Postnatal Care development
Commentary · 29 Jan 2025 Preclinical Testing: A Critical Step in Drug Development
Preclinical testing is a vital phase in the drug development process that assesses the safety and efficacy of potential therapeutic candidates before they are tested in humans. This article explores ... objectives…
Conference abstract · 7 Sep 2017 Preclinical development of a novel glutarimide derivative – a candidate oral drug for allergic asthma therapy
We tested the efficacy of a novel biogenic peptidoamine compound, glutarimide histamine
Opinion · 24 Feb 2023 Primary Development and Preclinical Drug Safety
Mini review · 7 May 2023 The Thought about Bioscience Translation into Drug Development Progress
Nowadays, the scientific community is divided into pro-animal testing supporters, and
Short communication · 28 May 2021 Preclinical Evaluation of Marine Natural Products for Neuroscience Drug Development
drug development. In addition to our laboratory work, we curate an up-to-date Global Marine Pharmaceuticals Pipeline https://www.marinepharmacology.org/ to track marine drugs through the clinical and preclinical pipeline
Mini review · 27 Feb 2023 Revolutionizing Healthcare: Exploring the Frontiers of Drug Development
improve patient outcomes. The article outlines the key stages involved in drug development, including target identification, preclinical testing, clinical trials, and regulatory approval. Additionally, it discusses the…
Conference abstract · 28 Jun 2022 The Perspective of preclinical toxicology in drug development
Drug Discovery and Development continues to exhibit more than 90 per cent attrition mainly due to the lack of success in translating preclinical efficacy and safety data into successful human ... studies in pre-clinical…
Short communication · Jun 2021 Perspective of Preclinical Toxicology in Drug Development
Drug Discovery and Development continues to exhibit more than 90 per cent attrition mainly due to the lack of success in translating preclinical efficacy and safety data into successful human ... studies in pre-clinical…
Short communication · 27 Feb 2021 Perspective of Preclinical Toxicology in Drug Development
Drug Discovery and Development continues to exhibit more than 90 per cent attrition mainly due to the lack of success in translating preclinical efficacy and safety data into successful human ... studies in pre-clinical…
Commentary · 13 Jun 2023 Developing Novel Therapeutics: Pioneering Advances in Healthcare
Research article · 16 Sep 2019 The i-screen: A Versatile Preclinical Platform for Gut Microbiota Studies
The gut microbiota is the complex community of microorganisms that inhabit the
Review article · 28 Apr 2023 Drug Development: Stages, Challenges, and Importance
molecules, and conducting preclinical and clinical trials to determine the drug's safety and efficacy. The article also highlights the challenges in drug development, such as finding promising drug targets ... process…
Perspective · 28 Feb 2022 Presymptomatic development of Orally Inhaled Drugs (OIDs)
treatment of systemic illnesses. However, the development of OIDs currently has a 70% attrition rate, meaning that seven out of ten novel drug candidates never make it to the clinic ... discussion focuses on the factors…
Commentary · 12 Sep 2023 Preclinical Studies in Rare Disease Drug Development
Conference abstract · 28 Sep 2022 Perspective of preclinical and Clinical toxicology in drug development
GM1 gangliosidosis is an autosomal recessive lysosomal storage sickness characterised through the
Conference abstract · 2 Jun 2025 Global drug development: Current trends, challenges and opportunities
Abstract: The entire process of developing a drug from preclinical research to marketing can take approximately 12 to 18 years and often costs well over $1 billion. Global Top Pharmaceutical ... billion in 2023 and is…
Editorial · 30 Jun 2025 Drug Development: From Discovery to Therapeutic Innovation
encompasses stages from initial discovery, preclinical studies, clinical trials, regulatory approval, and post-marketing surveillance. This article provides an overview of the drug development process, highlighting key…
Case report · 31 Jul 2023 The Crucial Role of Preclinical Research in Advancing Medical Breakthroughs
medical breakthroughs by serving as the initial phase of drug discovery and development. This article highlights the significance of preclinical research in evaluating the safety, efficacy, and mechanism of action…
Mini review · 2017 Preclinical Cancer Models and Biomarkers for Drug Development: New Technologies and Emerging Tools
Background and purpose: Predicting the efficacy of anticancer therapy is the holy grail of drug development and treatment selection in the clinic. To achieve this goal, scientists require pre-clinical ... past several…
Conference abstract · 20 Oct 2014 Nematic protein organization technology: A powerful tool to track drugs toxicity and side effects already at early preclinical development
oxicity and lack of drug efficiency from preclinical to clinical phase, are two most important hinders for development of new therapies. These are mainly due to our lack of reliable
Review article · 1 Mar 2018 Preclinical developmental toxicity testing and advanced in-vitro stem cell based systems
Therapeutic development and drug discovery processes are heavily challenged by delays in the preclinical experimental stages before being offered for Phase 1 clinical trials. Accelerating the preclinical phase via novel…
Conference abstract · 1 Nov 2018 Single dose acute toxicology in preclinical trial: The basic step in drug discovery and development
The dose, in preclinical trial, refers to the amount of test material

